BENEFIX 1500 UNIT
COAGULATION FACTOR IX (RECOMBINANT) : 1500 UNIT · DIN 02466619 · PFIZER CANADA ULC
Health Canada status: APPROVED
What is BENEFIX?
BENEFIX 1500 UNIT contains COAGULATION FACTOR IX (RECOMBINANT) : 1500 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02466619, held by PFIZER CANADA ULC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as approved, status dated 21-Jul-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02466619 |
|---|---|
| Brand name | BENEFIX |
| Generic / active ingredient | COAGULATION FACTOR IX (RECOMBINANT) : 1500 UNIT |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 1500 UNIT |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Schedule D |
| ATC code | B02BD04 COAGULATION FACTOR IX |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 21-Jul-2017 |
What can be used instead?
Other Canadian products sharing ATC code B02BD04 COAGULATION FACTOR IX. 16 of 33 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALPROLIX | 1000 UNIT | KIT ; POWDER FOR SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422921 |
| ALPROLIX | 2000 UNIT | POWDER FOR SOLUTION ; KIT | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422948 |
| ALPROLIX | 3000 UNIT | KIT ; POWDER FOR SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422956 |
| ALPROLIX | 500 UNIT | KIT ; POWDER FOR SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02422913 |
| BENEFIX | 1000 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02293781 |
| BENEFIX | 2000 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02293803 |
| BENEFIX | 3000 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02392984 |
| BENEFIX | 500 UNIT | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02293773 |
| IMMUNINE VH | 720 UNIT / 5 ML | POWDER FOR SOLUTION | TAKEDA CANADA INC | MARKETED | DIN 02206021 |
| REBINYN | 1000 UNIT | POWDER FOR SOLUTION | NOVO NORDISK CANADA INC | MARKETED | DIN 02470268 |
Who else supplies COAGULATION FACTOR IX worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COAGULATION FACTOR IX appears in 109 registered pack listings across 5 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.